A gradient of Shh establishes mutually repressing somitic cell fates induced by Nkx3.2 and Pax3

Dana M Cairns1, Mie Elissa Sato, Philip G Lee

  • 1Program in Cellular, Molecular and Developmental Biology, Sackler School of Graduate Biomedical Sciences, Tufts University, 136 Harrison Avenue, Boston, MA 02111, USA.

Developmental Biology
|September 18, 2008
PubMed

Insights

Sonic Hedgehog (Shh) signaling levels pattern somite development. Varying Shh concentrations, alongside Wnt signals, determine cell fates, with Pax3 and Nkx3.2 acting as key regulators in this developmental pathway.

Area of Science:

  • Developmental Biology
  • Molecular Biology
  • Genetics

Background:

  • Wnt and Sonic Hedgehog (Shh) signaling pathways are crucial for patterning embryonic somites.
  • Somites differentiate into dermomyotomal, myotomal, and sclerotomal cell lineages.

Purpose of the Study:

  • To investigate how varying levels of Shh signaling influence somite cell fate determination in the presence of Wnt signaling.
  • To elucidate the roles of transcription factors Pax3 and Nkx3.2 in Shh-mediated somite patterning.

Main Methods:

  • Culture of presomitic mesoderm explants with defined Wnt3a and Shh concentrations.
  • Analysis of gene expression for dermomyotomal, myotomal, and sclerotomal markers.
  • Forced expression studies of Pax3 and Nkx3.2 in vitro and in vivo.

Main Results:

  • Low Shh levels promote dermomyotomal gene expression.
  • Intermediate Shh levels induce myogenic differentiation.
  • High Shh levels activate sclerotomal gene expression, including Nkx3.2, while high Wnt levels maintain dermomyotomal/myotomal fates.
  • Nkx3.2 represses Pax3 expression, and Pax3 represses Shh-induced sclerotome differentiation.

Conclusions:

  • Shh acts as a morphogen, with different concentrations specifying distinct somite cell fates.
  • A regulatory loop between Pax3 and Nkx3.2 establishes mutually exclusive dermomyotome/myotome and sclerotome lineages.

Related Concept Videos

Determination01:51

Determination

During embryogenesis, cells become progressively committed to different fates through a two-step process: specification followed by determination. Specification is demonstrated by removing a segment of an early embryo, “neutrally” culturing the tissue in vitro—for example, in a petri dish with simple medium—and then observing the derivatives. If the cultured region gives rise to cell types that it would normally generate in the embryo, this means that it is specified. In contrast, determination...
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012 for this...